C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61P 37/06 (2006.01) C07K 16/28 (2006.01) C12N 5/10 (2006.01)
Patent
CA 2432736
The present invention provides anti-CD28 antibodies which are defective in mitogenic activity (silenced anti-CD28 antibodies), methods of producing, compositions containing the antibody and methods of immunosuppression, inducing T-cell tolerance and treating organ and/or tissue transplant rejections.
L'invention concerne des anticorps anti-CD28 défectueux en activité mitogène (anticorps anti-CD28 silencieux), leurs procédés de fabrication, des compositions contenant l'anticorps et des procédés d'immunosuppression, induisant la tolérance de cellules T et traitant de rejets de greffes d'organes et/ou de tissus.
Higashi Yasuyuki
Hinton Paul
Seki Nobuo
Tamura Kouichi
Tso J. Yun
Astellas Pharma Inc.
Higashi Yasuyuki
Hinton Paul
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Seki Nobuo
LandOfFree
Silenced anti-cd28 antibodies and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Silenced anti-cd28 antibodies and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Silenced anti-cd28 antibodies and use thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2073270